This company has been marked as potentially delisted and may not be actively trading. NASDAQ:TLMD SOC Telemed (TLMD) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About SOC Telemed Stock (NASDAQ:TLMD) 30 days 90 days 365 days Advanced Chart Get SOC Telemed alerts:Sign Up Key Stats Today's Range$3.00▼$3.0050-Day Range$2.90▼$3.0052-Week Range$0.55▼$8.00VolumeN/AAverage Volume1.28 million shsMarket Capitalization$302.52 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview SOC Telemed, Inc. provides acute care telemedicine services and technology to hospitals, health systems, physician groups, and government organizations in the United States. The company's Telemed IQ, a cloud-based software platform provides telemedicine solutions. Its telemedicine solutions include teleNeurology, telePulmonology, telePsychiatry, telecardiology, teleCritical Care (ICU), and other specialties. The company was founded in 2004 and is based in Herndon, Virginia. As of April 6, 2022, SOC Telemed, Inc. was taken private. Read More Receive TLMD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for SOC Telemed and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. TLMD Stock News HeadlinesThe Woman’s World Expert-Reviewed Glossary of GLP-1, Semaglutide and TelehealthNovember 14, 2024 | yahoo.comTrial reveals success of telemedicine-supported, village doctor–led approach to managing atrial fibrillationSeptember 2, 2024 | msn.comForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it could transform warfare, robotics, and the global economy. But you don’t need to buy Tesla or wait for xAI to IPO to benefit. One overlooked public company is supplying the critical tech behind Musk’s AI push — and it trades for a fraction of Nvidia’s price. Hedge funds are already loading up, but most investors haven’t noticed yet.September 1 at 2:00 AM | Behind the Markets (Ad)Explore the Innovations of Dr. Todd H. Lanman: An Influence in Spinal NeurosurgeryAugust 27, 2024 | usatoday.comTelemedicine usage can have unexpected impact on rural communities' access to local careAugust 2, 2024 | msn.comAccess to remote learning, telemedicine during extreme weather events ending for millionsMay 2, 2024 | nypost.comNUT Southwestern, Dallas telemedicine company partner on study to improve heart health in rural communitiesApril 4, 2024 | bizjournals.com(LEAD) Gov't to fully allow telemedicine services in case of doctors' collective actionFebruary 19, 2024 | msn.comSee More Headlines TLMD Stock Analysis - Frequently Asked Questions How were SOC Telemed's earnings last quarter? SOC Telemed, Inc. (NASDAQ:TLMD) released its earnings results on Friday, November, 12th. The company reported ($0.11) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.20) by $0.09. The company had revenue of $26.68 million for the quarter, compared to analyst estimates of $25.90 million. SOC Telemed had a negative net margin of 53.52% and a negative trailing twelve-month return on equity of 34.32%. What other stocks do shareholders of SOC Telemed own? Based on aggregate information from My MarketBeat watchlists, some other companies that SOC Telemed investors own include Meta Platforms (META), Advanced Micro Devices (AMD), Asana (ASAN), NVIDIA (NVDA), QUALCOMM (QCOM), Velodyne Lidar (VLDR) and Axcelis Technologies (ACLS). Company Calendar Last Earnings11/12/2021Today9/01/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Miscellaneous Health & Allied Services Sub-IndustryN/A Current SymbolNASDAQ:TLMD CIK1791091 Webwww.soctelemed.com Phone866-483-9690FaxN/AEmployees226Year FoundedN/AProfitability EPS (Trailing Twelve Months)($0.57) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$50.54 million Net Margins-53.52% Pretax Margin-53.68% Return on Equity-34.32% Return on Assets-20.96% Debt Debt-to-Equity Ratio0.52 Current Ratio3.32 Quick Ratio3.28 Sales & Book Value Annual Sales$94.44 million Price / Sales3.20 Cash FlowN/A Price / Cash FlowN/A Book Value$1.66 per share Price / Book1.81Miscellaneous Outstanding Shares100,840,000Free Float93,882,000Market Cap$302.52 million OptionableOptionable Beta-1.44 7 Stocks to Buy And Hold ForeverEnter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report This page (NASDAQ:TLMD) was last updated on 9/1/2025 by MarketBeat.com Staff From Our PartnersRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe $365M annual revenue crypto play While Bitcoin generates zero operational revenue, one DeFi protocol qu...Crypto 101 Media | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredOne tiny company just cracked Google’s $19B problemAn MIT lab recently cracked a code scientists had been chasing for decades… Turning a “miracle metal” from ...True Market Insiders | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredA Major Economic Change Is Happening NowLouis Navellier is one of Wall Street’s most respected money managers — overseeing more than $7 billion and ea...InvestorPlace | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…A new set of 7 AI stocks are DOMINATING the market. Here’s why one financial guru says they could be the mo...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SOC Telemed, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share SOC Telemed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
